SPI Infoamtion

このレポートは章ごとの個別販売も行っておりますのでお問い合わせ下さい。
※全てPDFでの販売となります。

Chapter- 1: INTRODUCTION

STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
INTENDED AUDIENCE
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ABOUT THE AUTHOR
RELATED BCC RESEARCH REPORTS
BCC ONLINE SERVICES
DISCLAIMER

Chapter-2: SUMMARY

SUMMARY
SUMMARY TABLE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2014 ($ BILLIONS)
SUMMARY FIGURE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2007-2014 ($ BILLIONS)

Chapter-3: OVERVIEW

DEFINITIONS
CONTRACT MANUFACTURING
CONTRACT MANUFACTURER
TYPES OF CONTRACT MANUFACTURERS
CORE COMPETENCIES
VENDOR
CONTRACT RESEARCH ORGANIZATION (CRO)
HISTORY OF OUTSOURCING

Chapter-4: CONTRACT MANUFACTURING

NEED FOR CONTRACT MANUFACTURING
FLEXIBILITY
CAPACITY AND CAPITAL
RISK
ADVANTAGES OF CONTRACT MANUFACTURING
TABLE 1 KEY ADVANTAGES OF CONTRACT MANUFACTURING
SELECTION OF CONTRACT MANUFACTURER
MISCONCEPTIONS REGARDING CONTRACT MANUFACTURERS

Chapter-5: CONTRACT RESEARCH

INCLUDED IN RESEARCH
DRUG DISCOVERY AND DEVELOPMENT
CLINICAL RESEARCH
ANALYTICAL RESEARCH
NEED FOR CONTRACT RESEARCH
SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATION
SELECTION AND MANAGEMENT OF CRO

Chapter-6: CONTRACT PACKAGING

CONTRACT PACKAGING
THE NEED FOR CONTRACT PACKAGING
CRITERIA FOR THE SELECTION OF A PACKAGING SERVICE
LOCATION
EXPERIENCE
PERSONALITY
FINANCIAL STRENGTH
ADVANTAGES OF CONTRACT PACKAGING

Chapter-7: THE NEED FOR PROJECT MANAGEMENT

PROJECT EVALUATION AND SET UP
PLANNING AND EXECUTION
QUALITY MANAGEMENT
MANAGEMENT OF QUALITY COMPONENTS FROM CLIENT’S PERSPECTIVE
MANAGEMENT OF QUALITY COMPONENTS FROM THE CMO PERSPECTIVE

Chapter-8: REGULATORY ASPECTS

SHORT SUPPLY ARRANGEMENTS
DIVIDED MANUFACTURING ARRANGEMENTS
SHARED MANUFACTURING ARRANGEMENTS
RESPONSIBILITIES OF EACH PARTICIPATING MANUFACTURER
CONTRACT MANUFACTURING ARRANGEMENTS
RESPONSIBILITIES OF LICENSED MANUFACTURER
TABLE 2 RESPONSIBILITIES OF LICENSED MANUFACTURER UNDER FDA ACTS
RESPONSIBILITIES OF THE CONTRACT MANUFACTURER
WARNING LETTERS
WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS
APPROVALS OF MANUFACTURING FACILITIES

Chapter-9: INDUSTRY STRUCTURE

MARKET SHARES OF INDUSTRY LEADERS
CONTRACT MANUFACTURERS OF BULK DRUGS AND APIS
TABLE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%)
FIGURE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%)
CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS
TABLE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%)
FIGURE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%)
CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
NONSTERILE
TABLE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%)
FIGURE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%)
STERILE
TABLE 6 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%)
FIGURE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%)
CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS
TABLE 7 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%)
FIGURE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%)
CONTRACT RESEARCH COMPANIES
TABLE 8 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%)
FIGURE 6 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%)
CONTRACT PACKAGING COMPANIES
TABLE 9 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%)
FIGURE 7 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%)
TYPES OF CONTRACT MANUFACTURING AND RESEARCH FIRMS
TABLE 10 SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH FIRMS
TABLE 11 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE

Chapter-10: TECHNOLOGY TRANSFER

REASONS FOR TECHNOLOGY TRANSFER
CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER
PRELIMINARY STEPS TOWARD TECHNOLOGY TRANSFER
STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER
TYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFER
CONFIDENTIAL DISCLOSURE AGREEMENT (CDA)
MATERIAL TRANSFER AGREEMENT (MTA)
ASSIGNMENT DEED
LICENSE AGREEMENT
CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS
FACTORS FOR A SUCCESSFUL PROJECT

Chapter-11: NEW DEVELOPMENTS

QUINTILES INC.
COVANCE
CHARLES RIVER LABORATORIES
OTHERS

Chapter-12: MARKETS

CONTRACT MANUFACTURING
CONTRACT MANUFACTURE OF BULK DRUGS/APIS
Market Overview
Market Revenue
TABLE 12 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
FIGURE 8 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
Market Shares
TABLE 13 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
FIGURE 9 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
CONTRACT MANUFACTURE OF ORAL DOSAGE FORMULATIONS
Solid Dosage Formulations
Market Overview
Market Revenue
TABLE 14 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
FIGURE 10 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
Market Shares
TABLE 15 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
FIGURE 11 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
Market by Formulation
Market Revenue
TABLE 16 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ BILLIONS)
FIGURE 12 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ BILLIONS)
TABLE 17 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
FIGURE 13 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING, MARKET SHARES BY FORMULATION, 2009 (%)
Liquid Dosage Formulations
Market Overview
Non-sterile Formulations
Market Revenue
TABLE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
FIGURE 14 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
Market Shares
TABLE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 15 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
Sterile Formulations
Market Revenue
TABLE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
FIGURE 16 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
Market Shares
TABLE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
FIGURE 17 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
Market by Formulation
Non-sterile Formulations
TABLE 22 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
FIGURE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS)
TABLE 23 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
FIGURE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
Sterile Formulations
TABLE 24 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
FIGURE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS)
TABLE 25 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
FIGURE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONS
Market Overview
Market Revenue
TABLE 26 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
FIGURE 22 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
Market Shares
TABLE 27 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
FIGURE 23 WORLDWIDE SEMI-SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
Market by Formulation
TABLE 28 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
FIGURE 24 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
TABLE 29 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
FIGURE 25 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTS
Market Overview
TABLE 30 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS
Market Revenue
TABLE 31 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
FIGURE 26 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
Market Shares
TABLE 32 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
FIGURE 27 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
Market by Formulation
TABLE 33 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY TYPE, THROUGH 2014 ($ BILLIONS)
FIGURE 28 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2007-2014 ($ BILLIONS)
Market Shares
TABLE 34 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING SHARE BY TYPE, 2009 (%)
FIGURE 29 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2009 (%)
CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL PRODUCTS
Market Overview
Market Revenue
TABLE 35 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
FIGURE 30 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
Market Shares
TABLE 36 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
FIGURE 31 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
Market by Formulation
TABLE 37 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, THROUGH 2014 ($ BILLIONS)
FIGURE 32 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, 2007-2014 ($ BILLIONS)
TABLE 38 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%)
FIGURE 33 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%)
CONTRACT RESEARCH
MARKET OVERVIEW
Partnerships
Expansions of Facilities
MARKET REVENUE
TABLE 39 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, THROUGH 2014 ($ BILLIONS)
FIGURE 34 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, 2007-2014 ($ BILLIONS)
MARKET SHARES
TABLE 40 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%)
FIGURE 35 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%)
MARKET BY DISCIPLINE
TABLE 41 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, THROUGH 2014 ($ BILLIONS)
FIGURE 36 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, 2007-2014 ($ BILLIONS)
MARKET SHARES BY DISCIPLINE
TABLE 42 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%)
FIGURE 37 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%)
CONTRACT PACKAGING
MARKET OVERVIEW
MARKET REVENUE
TABLE 43 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, THROUGH 2014 ($ BILLIONS)
FIGURE 38 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, 2007-2014 ($ BILLIONS)
MARKET SHARES
TABLE 44 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%)
FIGURE 39 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%)
MARKET BY PACKAGE TYPE
MARKET REVENUE
TABLE 45 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, THROUGH 2014 ($ BILLIONS)
FIGURE 40 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, 2007-2014 ($ BILLIONS)
MARKET SHARES
TABLE 46 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%)
FIGURE 41 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%)

Chapter-13: CONTRACT MANUFACTURING APPLICATIONS

CARDIOVASCULAR DRUG MARKET
MARKET REVENUE
TABLE 47 WORLDWIDE REVENUE FROM CONTRACT MANUFACTURE OF CARDIOVASCULAR DRUGS BY REGION, THROUGH 2014 ($ MILLIONS)
FIGURE 42 WORLDWIDE CARDIOVASCULAR DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
REPRODUCTIVE DRUG MARKET
MARKET REVENUE
TABLE 48 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
FIGURE 43 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
ONCOLOGY DRUG MARKET
MARKET REVENUE
TABLE 49 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
FIGURE 44 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
ANALGESIC MARKET
MARKET REVENUE
TABLE 50 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
FIGURE 45 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
ANTIVIRAL DRUGS MARKET
MARKET REVENUE
TABLE 51 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
FIGURE 46 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
ANTIBIOTICS MARKET
MARKET REVENUE
TABLE 52 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
FIGURE 47 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
MARKETS FOR OTHER DRUGS
MARKET REVENUE
TABLE 53 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
FIGURE 48 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)

Chapter-14: PATENT ANALYSIS

PATENTS BY YEAR
TABLE 54 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009
FIGURE 49 NUMBER OF PATENTS BY YEAR, 2005-2009
FIGURE 50 NUMBER OF PATENTS BY YEAR, 2005--2009 (%)
PATENTS BY COMPANY
TABLE 55 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2009
PATENTS BY COUNTRY
TABLE 56 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2009
TABLE 57 PATENT SHARES BY COUNTRY, 2005-2009 (%)
FIGURE 51 PATENT SHARES BY COUNTRY, 2005-2009 (%)
PATENTS BY EMPHASIS
TABLE 58 PATENTS BY EMPHASIS, 2005-2009

Chapter-15: CURRENT ENVIRONMENT

OVERALL SITUATION OF THE CONTRACTING MARKET
CONTRACT MANUFACTURING OF API AND DOSAGE FORMS
CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS
CONTRACT RESEARCH
CONTRACT PACKAGING
SUCCESS FACTORS FOR CMOS
PRESENT SCENARIO OF THE CONTRACT MANUFACTURING MARKET
FROM THE PHARMACEUTICAL COMPANIES’ PERSPECTIVE
FROM CONTRACT MANUFACTURING ORGANIZATION’S PERSPECTIVE
FACTORS AFFECTING THE OUTSOURCING MARKET
COST CONTAINMENT
GLOBALIZATION
MERGERS AND ACQUISITIONS
REGULATORY REQUIREMENTS
NEED FOR SPECIALIZED SERVICES
COMPETITION WITHIN THE PHARMACEUTICAL INDUSTRY
INTRODUCTION OF NEW BIOTHERAPEUTICS

Chapter-16: COMPANY PROFILES

AAI PHARMA, INC.
ABBOTT LABORATORIES
AEROGEN, INC.
ALBANY MOLECULAR RESEARCH, INC.
ALCAN PACKAGING
ALKERMES, INC.
AMERISOURCE BERGEN
A. P. PHARMA, INC.
ARADIGM CORPORATION
BAXTER HEALTHCARE
BEN VENUE LABORATORIES INC.
BIOVAIL CORP.
BOEHRINGER INGELHEIM
BOOTS MANUFACTURING
CAMBREX CORP.
CANGENE
CATALENT PHARMA SOLUTIONS
CEDARBURG HAUSER PHARMACEUTICAL LTD.
CENEXI
CHARLES RIVER LABORATORIES
CHEMBRIDGE CORP.
CONFAB LABORATORIES
COVANCE INC.
DAVOS PHARMA
DECODE GENETICS
DIOSYNTH BIOTECHNOLOGY
DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.
DOW CHEMICAL COMPANY
DPT LABORATORIES INC.
DR REDDY’S LABORATORIES
DSM PHARMACEUTICAL PRODUCTS
ELAN DRUG TECHNOLOGIES
EVOTEC AG
FULCRUM PHARMA PLC
GENZYME PHARMACEUTICALS
GIRINDUS AG
GLAXOSMITHKLINE BIOPHARMACEUTICALS
HOVIONE S.A.
JUBILANT ORGANOSYS
KENDLE INTERNATIONAL INC.
KING PHARMACEUTICALS
KP PHARMACEUTICAL TECHNOLOGIES INC
K.V. PHARMACEUTICAL CO.
LIGAND PHARMACEUTICALS
LONZA GROUP
LYNE LABORATORIES
MALLINCKRODT
MDS PHARMA SERVICES
MEDAREX INC.
MIKART INC
NORWICH PHARMACEUTICALS
NOVAVAX, INC.
OMNICARE CLINICAL RESEARCH
PAREXEL INTERNATIONAL CORPORATION
PATHEON INC.
PERRIGO COMPANY
PHARMACEUTICAL PRODUCT DEVELOPMENT INC.
PIRAMAL HEALTHCARE
PRA INTERNATIONAL
QUINTILES
RANBAXY RESEARCH LABS
REGIS TECHNOLOGIES, INC.
SCHWARZ PHARMA AG
SKYEPHARMA
TALECRIS BIOTHERAPEUTICS INC.
WUXI APP TEC
XCELLEREX, LLC
APPENDIX : ABBREVIATIONS
APPENDIX